Given the growing evidence linking these regulatory factors to liver energy homeostasis and the progression of NASH, the findings highlight the importance of the potential humoral crosstalk between fat tissue, muscle and liver via production and release of Mstn and adiponectin and the opposing actions of these regulatory factors. Here, ADIPOQ is linked to metabolic dysfunction-associated steatohepatitis.